申请人:Merck & Co., Inc.
公开号:US04533671A1
公开(公告)日:1985-08-06
New 5-(2,3-dihydro-1H-pyrrolizin-5-oyl)-, 5-(2,3-dihydro-1H-pyrrolo[2,1-b]thiazol-5-oyl)-, 5-(2,3-dihydro-1H-pyrrolo[2,1-b]imidazol-5-oyl)-, and 5-(2,3-dihydro-1H-pyrrolo[2,1-b]oxazol-5-oyl)-pyrrole-2-alkanoic acid derivatives have been prepared. They are found to be effective inhibitors of platelet aggregation and are analgesic and anti-inflammatory agents with low ulcerogenic side effects.
新的5-(2,3-二氢-1H-吡咯烷-5-酰基)-,5-(2,3-二氢-1H-吡咯并[2,1-b]噻唑-5-酰基)-,5-(2,3-二氢-1H-吡咯并[2,1-b]咪唑-5-酰基)-和5-(2,3-二氢-1H-吡咯并[2,1-b]噁唑-5-酰基)-吡咯-2-脂肪酸衍生物已经制备。它们被发现是有效的血小板聚集抑制剂,并且是具有低溃疡副作用的镇痛和抗炎药物。